Sales rise 16.64% to Rs 1815.14 crore
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 as against Rs 130.41 crore during the previous quarter ended June 2023. Sales rose 16.64% to Rs 1815.14 crore in the quarter ended June 2024 as against Rs 1556.16 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1815.141556.16 17 OPM %18.5319.00 -PBDT301.00258.52 16 PBT207.41191.34 8 NP144.08130.41 10Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Sheikh Hasina")
 "BSE, NSE, Sensex, Nifty, stock markets")
 "Kylian Mbappe,Kylian, Mbappe")
 "Fumio Kishida, Fumio, Japan PM")
